Drug
HS 20094
HS 20094: highest development phase Phase 3, developed by Hansoh Pharmaceutical. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Hansoh Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| HS-20094 Injection NCT07156539 | Phase 3 | Type 2 Diabetes |
| HS-20094 NCT06118021 | Phase 2 | Overweight and Obesity |
| HS-20094 5mg NCT06118008 | Phase 2 | Type 2 Diabetes |
Latest
No recent events.
Follow HS 20094 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.